Eric Zhang - 23 Sep 2022 Form 4 Insider Report for Aravive, Inc. (ARAV)

Role
Director
Signature
/s/ Abel Svitavsky, Attorney-In-Fact
Issuer symbol
ARAV
Transactions as of
23 Sep 2022
Transactions value $
$0
Form type
4
Filing time
26 Sep 2022, 16:07:21 UTC
Previous filing
13 Sep 2021
Next filing
27 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARAV Stock Option (Right to Buy) Award $0 +97.1K $0.00 97.1K 23 Sep 2022 Common Stock 97.1K $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders.